Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Para-sternal block with ropivacaine after sternotomy cardiac surgery
2024-513301-30-00Phase 4Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- May 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine in cardiac surgery (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Change in forced vital capacity (FVC) from preoperative to postoperative day 1. Started May 2024; status: completed.
02
Drugs
ropivacaine
03
Conditions
cardiac surgery
Beyond the preview
Go deeper on 2024-513301-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513301-30-00.